BARACLUDE Side Effects

7019840-8 | Pancytopenia
on Sep 27, 2010 Male patient from JAPAN , 49 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Baraclude dosage: .

7017402-X | Caesarean Section, Delivery, Pregnancy
Patient was taking Baraclude (View Usage). Patient had the following side effects: caesarean section, delivery, pregnancy (What is pregnancy?) on Sep 17, 2010 from JAPAN Additional patient health information: Female patient , 48 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: .

7014803-0 | Alanine Aminotransferase Increased, Blood Glucose Increased, Hepatitis B Dna Increased
Adverse event was reported on Sep 24, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: Interrupted In Jul2009.restarted In Dec2009 With 0.5mgqd) was diagnosed with hepatitis b (What is hepatitis b?), hyperglycaemia and. Location: CHINA , 52 years of age, After Baraclude was administered, patient had the following side effects: alanine aminotransferase increased, blood glucose increased, hepatitis b dna increased. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

7012472-7 |
on Sep 22, 2010 Male patient from ITALY , 80 years of age, was treated with Baraclude (View Usage). . Baraclude dosage: .


7002468-3 | Abdominal Pain Upper, Hepatomegaly
on Sep 16, 2010 Male patient from CHINA , 42 years of age, was diagnosed with chronic hepatitis and was treated with Baraclude (View Usage). Patient had the following side effects: abdominal pain upper, hepatomegaly. Baraclude dosage: . Patient was hospitalized.

6993002-2 | Alanine Aminotransferase Increased, Blood Glucose Increased, Hepatitis B Dna Increased
Patient was taking Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: alanine aminotransferase increased, blood glucose increased, hepatitis b dna increased on Sep 13, 2010 from CHINA Additional patient health information: Male patient , 52 years of age, was diagnosed with hepatitis b (What is hepatitis b?), hyperglycaemia and. Baraclude dosage: Interrupted In Jul2009.restarted On Dec2009 With 0.5mgqd. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6992209-8 | Abortion Induced, Pregnancy
Adverse event was reported on Sep 15, 2010 by a Female patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: CHINA , 25 years of age, Patient experienced the following unwanted or unexpected effects: abortion induced, pregnancy (What is pregnancy?).

6992206-2 | Abdominal Pain Upper, Angina Pectoris, Mood Altered
on Sep 14, 2010 Male patient from CHINA , 32 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: abdominal pain upper, angina pectoris, mood altered. Baraclude dosage: Taken For 6 Months.

6985610-X | Thrombotic Thrombocytopenic Purpura
on Sep 08, 2010 Male patient from JAPAN , 49 years of age, weighting 136.7 lb, was diagnosed with hepatitis b (What is hepatitis b?), nausea (What is nausea?), constipation (What is constipation?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: thrombotic thrombocytopenic purpura. Baraclude dosage: Also On 10jul2010. During the same period patient was treated with PRIMPERAN TAB (Tablet) (View Primperan Tab Review and Primperan Tab Label ), LOXONIN (Tablet) (View Loxonin Review and Loxonin Label ), SELBEX (Capsule) (View Selbex Review and Selbex Label ), MAGMITT (Tablet) (View Magmitt Review and Magmitt Label ), STRONGER NEO MINOPHAGEN C (View Stronger Neo-minophagen C Review and Stronger Neo-minophagen C Label ). Patient was hospitalized.

6983374-7 | Haemolytic Anaemia, Lung Disorder, Pyrexia
Patient was taking Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, lung disorder, pyrexia on Sep 10, 2010 from FRANCE Additional patient health information: Male patient , 25 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: 1 Tab/day.

6978400-5 | Abdominal Pain Upper, Hepatic Neoplasm Malignant
Adverse event was reported on Sep 03, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: ITALY , 57 years of age, Patient had the following side effects: abdominal pain upper, hepatic neoplasm malignant. Patient was hospitalized.

6971292-X | Hepatic Neoplasm Malignant
on Sep 01, 2010 Male patient from JAPAN , 90 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: hepatic neoplasm malignant. Baraclude dosage: . Patient was hospitalized.

6966780-6 | Caesarean Section, Delivery, Pregnancy
on Aug 30, 2010 Female patient from JAPAN , 48 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, delivery, pregnancy (What is pregnancy?). Baraclude dosage: .

6966757-0 | Anaemia, Platelet Count Decreased, Thrombotic Thrombocytopenic Purpura
Patient was taking Baraclude (View Usage). Patient had the following side effects: anaemia, platelet count decreased, thrombotic thrombocytopenic purpura on Aug 26, 2010 from JAPAN Additional patient health information: Male patient , 49 years of age, weighting 136.7 lb, was diagnosed with hepatitis b (What is hepatitis b?), nausea (What is nausea?), pyrexia and. Baraclude dosage: Also On 10jul2010. During the same period patient was treated with PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), LOXONIN (View Loxonin Review and Loxonin Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

6955509-3 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Chromaturia, Ocular Icterus
Adverse event was reported on Aug 23, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: CHINA , 40 years of age, After Baraclude was administered, patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, chromaturia, ocular icterus.

6955508-1 | Eczema, Hepatic Cirrhosis
on Aug 20, 2010 Male patient from CHINA , 41 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: eczema (What is eczema?), hepatic cirrhosis. Baraclude dosage: .

6941062-7 | Abortion Induced, Pregnancy
on Aug 19, 2010 Female patient from CHINA , 25 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: abortion induced, pregnancy (What is pregnancy?). Baraclude dosage: .

6941053-6 | Abortion Induced, Pregnancy
Patient was taking Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: abortion induced, pregnancy (What is pregnancy?) on Aug 20, 2010 from CHINA Additional patient health information: Male patient , 44 years of age, was diagnosed with hepatitis b virus test and. Baraclude dosage: .

6936907-0 | Haematemesis, Pulmonary Alveolar Haemorrhage
Adverse event was reported on Aug 19, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: JAPAN , 41 years of age, Patient experienced the following unwanted or unexpected effects: haematemesis, pulmonary alveolar haemorrhage. Patient was hospitalized.

6936000-7 | Hepatic Neoplasm Malignant
on Aug 18, 2010 Male patient from FRANCE , 65 years of age, was treated with Baraclude (View Usage). Patient had the following side effects: hepatic neoplasm malignant. Baraclude dosage: .

6933559-0 | Amenorrhoea
on Aug 13, 2010 Female patient from TURKEY , 18 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: amenorrhoea. Baraclude dosage: .

6933515-2 | Hepatomegaly
Patient was taking Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: hepatomegaly on Aug 13, 2010 from CHINA Additional patient health information: Male patient , 42 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: .

6933105-1 | Thrombotic Thrombocytopenic Purpura
Adverse event was reported on Aug 16, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis acute and. Location: JAPAN , 49 years of age, Patient had the following side effects: thrombotic thrombocytopenic purpura.

6933100-2 | Hepatitis B Dna Increased
on Aug 13, 2010 Male patient from UNITED STATES , 42 years of age, was diagnosed with immune reconstitution syndrome and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: hepatitis b dna increased. Baraclude dosage: . During the same period patient was treated with EFAVIRENZ CAPS (View Efavirenz Caps Review and Efavirenz Caps Label ), TRUVADA (View Truvada Review and Truvada Label ).

6930846-7 | Depression
on Aug 13, 2010 Male patient from NETHERLANDS , 45 years of age, weighting 187.4 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?). Baraclude dosage: .

6930830-3 | Hepatic Neoplasm Malignant Recurrent
Patient was taking Baraclude (View Usage). Patient had the following side effects: hepatic neoplasm malignant recurrent on Aug 16, 2010 from CHINA Additional patient health information: Male patient , 56 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: .

6928821-1 | Hepatic Neoplasm Malignant
Adverse event was reported on Aug 11, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: 17jan08:12mar08:0.5mgx1 Mg/d 13mar08:ong:1mgx1 Mg/d) was diagnosed with hepatitis b (What is hepatitis b?), hepatitis b dna increased and. Location: JAPAN , 69 years of age, weighting 165.3 lb, After Baraclude was administered, patient had the following side effects: hepatic neoplasm malignant. During the same period patient was treated with URSO 250 (Tabs) (View Urso 250 Review and Urso 250 Label ), HEPSERA (Tabs) (View Hepsera Review and Hepsera Label ). Patient was hospitalized.

6928804-1 | Hepatic Neoplasm Malignant
on Aug 12, 2010 Male patient from FRANCE , 65 years of age, was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant. Baraclude dosage: .

6923712-4 | Dizziness, Face Oedema, Headache, Rash, Retinal Haemorrhage
on Aug 10, 2010 Female patient from CHINA , 62 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: dizziness (What is dizziness?), face oedema, headache (What is headache?), rash (What is rash?), retinal haemorrhage. Baraclude dosage: For 20 Days. During the same period patient was treated with FUZHENG HUAYU (View Fuzheng Huayu Review and Fuzheng Huayu Label ).

6923295-9 | Hepatic Neoplasm Malignant Recurrent
Patient was taking Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: hepatic neoplasm malignant recurrent on Aug 09, 2010 from JAPAN Additional patient health information: Male patient , 49 years of age, was diagnosed with hepatitis b (What is hepatitis b?), hepatic cirrhosis, lung cancer metastatic and. Baraclude dosage: . During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ), LIVACT (View Livact Review and Livact Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), TS 1 (View Ts-1 Review and Ts-1 Label ). Patient was hospitalized.

6920625-9 | Bradykinesia, Epistaxis, Hyperammonaemia
Adverse event was reported on Aug 02, 2010 by a Female patient taking Baraclude (View Usage) (Dosage: 26mar07-06jan08 0.5mg Once In Every Other Day 07jan-15jun08 0.5mg 2/wk 16jun08 0.5mg/wk) was diagnosed with hepatitis b (What is hepatitis b?), hypertension and. Location: JAPAN , 61 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: bradykinesia, epistaxis, hyperammonaemia. During the same period patient was treated with NORVASC (Formulation:tabs) (View Norvasc Review and Norvasc Label ), LASIX (Formulation:tabs) (View Lasix Review and Lasix Label ), ALDACTONE (Formulation:tabs) (View Aldactone Review and Aldactone Label ).

6918958-5 |
on Aug 06, 2010 Female patient from UNITED STATES , 61 years of age, was treated with Baraclude (View Usage). . Baraclude dosage: .

6916587-0 | Pyrexia, Splenectomy
on Aug 03, 2010 Male patient from CHINA , 55 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: pyrexia, splenectomy. Baraclude dosage: . Patient was hospitalized.

6916585-7 | Hepatic Neoplasm Malignant Recurrent
Patient was taking Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant recurrent on Aug 05, 2010 from CHINA Additional patient health information: Male patient , 56 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: .

6914068-1 | Abdominal Pain Upper, Hepatic Neoplasm Malignant
Adverse event was reported on Aug 02, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: ITALY , 55 years of age, Patient had the following side effects: abdominal pain upper, hepatic neoplasm malignant. Patient was hospitalized.

6911345-5 | Small Intestinal Perforation, Transaminases Increased
on Jul 30, 2010 Female patient from BRAZIL , 38 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: small intestinal perforation, transaminases increased. Baraclude dosage: Interrupted On Apr2010 And Restarted.. Patient was hospitalized.

6911337-6 | Somnolence, Suicide Attempt
on Aug 05, 2010 Female patient from GERMANY , 19 years of age, weighting 143.3 lb, was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: somnolence, suicide attempt. Baraclude dosage: Totally 15 Tabs 0.5mg. During the same period patient was treated with SEROQUEL (Total - 10 Tabs) (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

6899914-2 | Epilepsy, Thrombocytopenia
Patient was taking Baraclude (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?), thrombocytopenia on Jul 23, 2010 from GERMANY Additional patient health information: Male patient , 52 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6883912-9 | Blood Uric Acid Increased
Adverse event was reported on Jul 27, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: CHINA , 64 years of age, After Baraclude was administered, patient had the following side effects: blood uric acid increased.

6881465-2 | Jaundice, Platelet Count Decreased, Pruritus, White Blood Cell Count Decreased
on Jul 22, 2010 Male patient from CHINA , 47 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), platelet count decreased, pruritus, white blood cell count decreased. Baraclude dosage: Initial Dose 1mg Qd Since. Taken For 2.5yrs.. Patient was hospitalized.

6876595-5 | Abortion Induced, Pregnancy
on Jul 13, 2010 Female patient from UNITED STATES , 25 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: abortion induced, pregnancy (What is pregnancy?). Baraclude dosage: .

6863161-0 | Hyperammonaemia, Lactic Acidosis, Loss Of Consciousness
Patient was taking Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: hyperammonaemia, lactic acidosis, loss of consciousness on Jul 16, 2010 from JAPAN Additional patient health information: Male patient , 45 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: . During the same period patient was treated with ALOSITOL (View Alositol Review and Alositol Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), GLYCYRON (View Glycyron Review and Glycyron Label ).

6863129-4 | Somnolence, Suicide Attempt
Adverse event was reported on Jul 19, 2010 by a Female patient taking Baraclude (View Usage) (Dosage: Totally 15 Tabs 0.5mg) . Location: GERMANY , 19 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: somnolence, suicide attempt. During the same period patient was treated with SEROQUEL (Total - 10 Tabs) (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

6855216-1 |
on Jul 14, 2010 Female patient from UNITED STATES , 53 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). . Baraclude dosage: .

6848599-X | Lactic Acidosis
on Jul 14, 2010 Male patient from UNITED STATES , 40 years of age, was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: lactic acidosis. Baraclude dosage: .

6844741-5 | Fatigue, Intentional Overdose, Suicide Attempt
Patient was taking Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, intentional overdose, suicide attempt on Jul 13, 2010 from GERMANY Additional patient health information: Female patient , 35 years of age, . Baraclude dosage: 40 Tablets.

6844726-9 | Oesophageal Varices Haemorrhage, Pneumonia Aspiration, Respiratory Failure, Septic Shock
Adverse event was reported on Jul 12, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?), hepatic cirrhosis, essential hypertension and. Location: ITALY , 59 years of age, Patient had the following side effects: oesophageal varices haemorrhage, pneumonia aspiration, respiratory failure, septic shock. During the same period patient was treated with ZESTORETIC (1df=1tab Strength-20mg+12.5mg) (View Zestoretic Review and Zestoretic Label ). Patient was hospitalized.

6843747-X |
on Jul 13, 2010 Female patient from UNITED STATES , 53 years of age, was treated with Baraclude (View Usage). . Baraclude dosage: .

6839671-9 | Photosensitivity Reaction
on Jul 06, 2010 Female patient from JAPAN , 54 years of age, was diagnosed with hepatitis b (What is hepatitis b?), breast cancer (What is breast cancer?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: photosensitivity reaction. Baraclude dosage: . During the same period patient was treated with TAXOL (28feb2008:66day) (View Taxol Review and Taxol Label ), HERCEPTIN (Frm 25dec07-28feb08-95mg,1 In 1 Wk,66 Days. Frm 6mar08-11dec08-285mg,1 In 3 Wk,281 Days.) (View Herceptin Review and Herceptin Label ), ZANTAC (View Zantac Review and Zantac Label ), RAMELTEON (View Ramelteon Review and Ramelteon Label ), ZITHROMAC (View Zithromac Review and Zithromac Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), DECADRON (View Decadron Review and Decadron Label ), POLARAMINE (View Polaramine Review and Polaramine Label ).

6834238-0 | Hepatic Neoplasm Malignant
Patient was taking Baraclude (View Usage). Patient had the following side effects: hepatic neoplasm malignant on Jul 07, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: . During the same period patient was treated with INTRON A (View Intron A Review and Intron A Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), SELBEX (View Selbex Review and Selbex Label ), VITAMEDIN (View Vitamedin Review and Vitamedin Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), FERON (View Feron Review and Feron Label ), AMLODIN (View Amlodin Review and Amlodin Label ). Patient was hospitalized.